|
Volumn 25, Issue 3, 2008, Pages 156-157
|
Epistaxis: When are coagulation studies justified?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
HEPARIN;
WARFARIN;
ADULT;
ARTICLE;
BLOOD CLOTTING DISORDER;
CHRONIC ACTIVE HEPATITIS;
CLINICAL EFFECTIVENESS;
COMORBIDITY;
CONTROLLED STUDY;
DIAGNOSTIC VALUE;
EPISTAXIS;
FEMALE;
HEMOPHILIA;
HUMAN;
HYPERTENSION;
INTERNATIONAL NORMALIZED RATIO;
LIVER CANCER;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD REVIEW;
PAKISTAN;
PARTIAL THROMBOPLASTIN TIME;
PRIORITY JOURNAL;
PROTHROMBIN TIME;
THROMBOCYTOPENIA;
ADULT;
BLOOD COAGULATION TESTS;
COMORBIDITY;
EMERGENCY SERVICE, HOSPITAL;
EPISTAXIS;
FEMALE;
HUMANS;
INTERNATIONAL NORMALIZED RATIO;
MALE;
RETROSPECTIVE STUDIES;
|
EID: 40449124370
PISSN: 14720205
EISSN: None
Source Type: Journal
DOI: 10.1136/emj.2006.038828 Document Type: Article |
Times cited : (18)
|
References (8)
|